Improved risk stratification in myeloma using a microRNA-based classifier

British Journal of Haematology

Volumn 162, Issue 3, 2013, Pages 348-359

  Wu, Ping ^a   Agnelli, Luca ^b,c   Walker, Brian A ^a   Todoerti, Katia ^b,c   Lionetti, Marta ^b,c   Johnson, David C ^a   Kaiser, Martin ^a   Mirabella, Fabio ^a   Wardell, Christopher ^a   Gregory, Walter M ^d   Davies, Faith E ^a   Brewer, Daniel ^a   Neri, Antonino ^b,c   Morgan, Gareth J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Genomic profiling; MicroRNA; Myeloma; Outcome classifier; Risk stratification

Indexed keywords

MICRORNA; MICRORNA 11Q13; MICRORNA 4P16; MICRORNA MAF; MICRORNA MIR106A; MICRORNA MIR106A 363; MICRORNA MIR125A 5P; MICRORNA MIR155; MICRORNA MIR17; MICRORNA MIR17HG; MICRORNA MIR18A; MICRORNA MIR18B; MICRORNA MIR19B1; MICRORNA MIR19B2; MICRORNA MIR20A; MICRORNA MIR20B; MICRORNA MIR363; MICRORNA MIR424 STAR; MICRORNA MIR503; MICRORNA MIR503 424; MICRORNA MIR542 5P; MICRORNA MIR570; MICRORNA MIR886 3P; MICRORNA MIR886 5P; MICRORNA MIR92A 1; MICRORNA MIR92A 2; MICRORNA MIR99B; MICRORNA MIRLET7E; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME ABERRATION; CLASSIFIER; COPY NUMBER VARIATION; CYTOGENETICS; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC RISK; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; INTERNATIONAL STAGING SYSTEM; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; OUTCOME CLASSIFIER; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; RNA TRANSPORT; TRANSCRIPTION REGULATION; UPREGULATION;

GENOMIC PROFILING; MICRORNA; MYELOMA; OUTCOME CLASSIFIER; RISK STRATIFICATION;

AGED; CHROMOSOME ABERRATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MICRORNAS; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; RISK ASSESSMENT; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84880309774     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12394     Document Type: Article

References (58)

1. Bagga, S., Bracht, J., Hunter, S., Massirer, K., Holtz, J., Eachus, R. & Pasquinelli, A.E. (2005) Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell, 122, 553-563.
2. Bergsagel, P.L., Kuehl, W.M., Zhan, F.H., Sawyer, J., Barlogie, B. & Shaughnessy, J. (2005) Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood, 106, 296-303.
3. Bierie, B. & Moses, H.L. (2006) TGF-beta and cancer. Cytokine & Growth Factor Reviews, 17, 29-40.
4. Boyd, K.D., Ross, F.M., Chiecchio, L., Dagrada, G.P., Konn, Z.J., Tapper, W.J., Walker, B.A., Wardell, C.P., Gregory, W.M., Szubert, A.J., Bell, S.E., Child, J.A., Jackson, G.H., Davies, F.E. & Morgan, G.J. (2012) A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia, 26, 349-355.
5. Calin, G.A. & Croce, C.M. (2006a) MicroRNA signatures in human cancers. Nature Reviews Cancer, 6, 857-866.
6. Calin, G.A. & Croce, C.M. (2006b) MicroRNA-cancer connection: the beginning of a new tale. Cancer Research, 66, 7390-7394.
7. Caramuta, S., Egyhazi, S., Rodolfo, M., Witten, D., Hansson, J., Larsson, C. & Lui, W.O. (2010) MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. The Journal of Investigative Dermatology, 130, 2062-2070.
8. Chang, T.C., Yu, D., Lee, Y.S., Wentzel, E.A., Arking, D.E., West, K.M., Dang, C.V., Thomas-Tikhonenko, A. & Mendell, J.T. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genetics, 40, 43-50.
9. Chen, L., Li, C., Zhang, R., Gao, X., Qu, X., Zhao, M., Qiao, C., Xu, J. & Li, J. (2011) miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. Cancer Letters, 309, 62-70.
10. Chi, J., Ballabio, E., Chen, X.H., Kusec, R., Taylor, S., Hay, D., Tramonti, D., Saunders, N.J., Littlewood, T., Pezzella, F., Boultwood, J., Wainscoat, J.S., Hatton, C.S. & Lawrie, C.H. (2011) MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biology Direct, 6, 23.
11. Chng, W.J., Huang, G.F., Chung, T.H., Ng, S.B., Gonzalez-Paz, N., Troska-Price, T., Mulligan, G., Chesi, M., Bergsagel, P.L. & Fonseca, R. (2011) Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. Leukemia, 25, 1026-1035.
12. Corbetta, S., Vaira, V., Guarnieri, V., Scillitani, A., Eller-Vainicher, C., Ferrero, S., Vicentini, L., Chiodini, I., Bisceglia, M., Beck-Peccoz, P., Bosari, S. & Spada, A. (2010) Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocrine-Related Cancer, 17, 135-146.
13. Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N. & Croce, C.M. (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proceedings of the National Academy of Sciences of the USA, 103, 7024-7029.
14. Decaux, O., Lode, L., Magrangeas, F., Charbonnel, C., Gouraud, W., Jezequel, P., Attal, M., Harousseau, J.L., Moreau, P., Bataille, R., Campion, L., Avert-Loiseau, H. & Minvielle, S. (2008) Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the intergroupe francophone du myelome. Journal of Clinical Oncology, 26, 4798-4805.
15. Deng, Z.B., Zhu, W., Lu, C.M., Shi, Q., Ju, S.G., Ma, H.B., Xu, Y. & Zhang, X.G. (2004) An agonist human ICOS monoclonal antibody that induces T cell activation and inhibits proliferation of a myeloma cell line. Hybridoma and Hybridomics, 23, 176-182.
16. Dews, M., Homayouni, A., Yu, D., Murphy, D., Sevignani, C., Wentzel, E., Furth, E.E., Lee, W.M., Enders, G.H., Mendell, J.T. & Thomas-Tikhonenko, A. (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics, 38, 1060-1065.
17. Dickens, N.J., Walker, B.A., Leone, P.E., Johnson, D.C., Brito, J.L., Zeisig, A., Jenner, M.W., Boyd, K.D., Gonzalez, D., Gregory, W.M., Ross, F.M., Davies, F.E. & Morgan, G.J. (2010) Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clinical Cancer Research, 16, 1856-1864.
18. Friedman, R.C., Farh, K.K., Burge, C.B. & Bartel, D.P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Research, 19, 92-105.
19. Gerrits, A., Walasek, M.A., Olthof, S., Weersing, E., Ritsema, M., Zwart, E., van Os, R., Bystrykh, L.V. & de Haan, G. (2012) Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells. Blood, 119, 377-387.
20. Guo, S., Lu, J., Schlanger, R., Zhang, H., Wang, J.Y., Fox, M.C., Purton, L.E., Fleming, H.H., Cobb, B., Merkenschlager, M., Golub, T.R. & Scadden, D.T. (2010) MicroRNA miR-125a controls hematopoietic stem cell number. Proceedings of the National Academy of Sciences of the USA, 107, 14229-14234.
21. Gutierrez, N.C., Sarasquete, M.E., Misiewicz-Krzeminska, I., Delgado, M., De Las, Rivas.J., Ticona, F.V., Ferminan, E., Martin-Jimenez, P., Chillon, C., Risueno, A., Hernandez, J.M., Garcia-Sanz, R., Gonzalez, M. & San Miguel, J.F. (2010) Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Leukemia, 24, 629-637.
22. Iqbal, J., Shen, Y., Liu, Y., Fu, K., Jaffe, E.S., Liu, C., Liu, Z., Lachel, C.M., Deffenbacher, K., Greiner, T.C., Vose, J.M., Bhagavathi, S., Staudt, L.M., Rimsza, L., Rosenwald, A., Ott, G., Delabie, J., Campo, E., Braziel, R.M., Cook, J.R., Tubbs, R.R., Gascoyne, R.D., Armitage, J.O., Weisenburger, D.D., McKeithan, T.W. & Chan, W.C. (2012) Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. Blood, 119, 4939-4948.
23. Jamieson, N.B., Morran, D.C., Morton, J.P., Ali, A., Dickson, E.J., Carter, C.R., Sansom, O.J., Evans, T.R., McKay, C.J. & Oien, K.A. (2012) MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clinical Cancer Research, 18, 534-545.
24. Jensen, N.F., Soekilde, R. & Stenvang, J. (2012) MicroRNAs related to intrinsic resistance to oxaliplatin and the irinotecan metabolite SN-38 in 10 colorectal cancer cell lines. Journal of Clinical Oncology, 30(Suppl. 4), abstr 524.
25. Jima, D.D., Zhang, J., Jacobs, C., Richards, K.L., Dunphy, C.H., Choi, W.W., Au, W.Y., Srivastava, G., Czader, M.B., Rizzieri, D.A., Lagoo, A.S., Lugar, P.L., Mann, K.P., Flowers, C.R., Bernal-Mizrachi, L., Naresh, K.N., Evens, A.M., Gordon, L.I., Luftig, M., Friedman, D.R., Weinberg, J.B., Thompson, M.A., Gill, J.I., Liu, Q., How, T., Grubor, V., Gao, Y., Patel, A., Wu, H., Zhu, J., Blobe, G.C., Lipsky, P.E., Chadburn, A. & Dave, S.S. (2010) Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood, 116, e118-e127.
26. Jing, Q., Huang, S., Guth, S., Zarubin, T., Motoyama, A., Chen, J., Di Padova, F., Lin, S.C., Gram, H. & Han, J. (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell, 120, 623-634.
27. Lee, K., Kunkeaw, N., Jeon, S.H., Lee, I., Johnson, B.H., Kang, G.Y., Bang, J.Y., Park, H.S., Leelayuwat, C. & Lee, Y.S. (2011) Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA, 17, 1076-1089.
28. Lee, H., Park, C.S., Deftereos, G., Morihara, J., Stern, J.E., Hawes, S.E., Swisher, E., Kiviat, N.B. & Feng, Q. (2012) MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World Journal of Surgical Oncology, 10, 174.
29. Li, J.H., Xiao, X., Zhang, Y.N., Wang, Y.M., Feng, L.M., Wu, Y.M. & Zhang, Y.X. (2011) MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecologic Oncology, 120, 145-151.
30. Lionetti, M., Biasiolo, M., Agnelli, L., Todoerti, K., Mosca, L., Fabris, S., Sales, G., Deliliers, G.L., Bicciato, S., Lombardi, L., Bortoluzzi, S. & Neri, A. (2009) Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood, 114, e20-e26.
31. Lionetti, M., Agnelli, L., Lombardi, L., Tassone, P. & Neri, A. (2012) MicroRNAs in the pathobiology of multiple myeloma. Current Cancer Drug Targets, 12, 823-837.
32. Liu, X., Lv, X.B., Wang, X.P., Sang, Y., Xu, S., Hu, K., Wu, M., Liang, Y., Liu, P., Tang, J., Lu, W.H., Feng, Q.S., Chen, L.Z., Qian, C.N., Bei, J.X., Kang, T. & Zeng, Y.X. (2012) MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle, 11, 2495-2506.
33. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., Downing, J.R., Jacks, T., Horvitz, H.R. & Golub, T.R. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
34. Michalek, J., Ocadlikova, D., Matejkova, E., Foltankova, V., Dudova, S., Slaby, O., Horvath, R., Pour, L. & Hajek, R. (2010) Individual myeloma-specific T-cell clones eliminate tumour cells and correlate with clinical outcomes in patients with multiple myeloma. British Journal of Haematology, 148, 859-867.
35. Montes-Moreno, S., Martinez, N., Sanchez-Espiridion, B., Diaz Uriarte, R., Rodriguez, M.E., Saez, A., Montalban, C., Gomez, G., Pisano, D.G., Garcia, J.F., Conde, E., Gonzalez-Barca, E., Lopez, A., Mollejo, M., Grande, C., Martinez, M.A., Dunphy, C., Hsi, E.D., Rocque, G.B., Chang, J., Go, R.S., Visco, C., Xu-Monette, Z., Young, K.H. & Piris, M.A. (2011) miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood, 118, 1034-1040.
36. Morgan, G.J., Davies, F.E., Gregory, W.M., Cocks, K., Bell, S.E., Szubert, A.J., Navarro-Coy, N., Drayson, M.T., Owen, R.G., Feyler, S., Ashcroft, A.J., Ross, F., Byrne, J., Roddie, H., Rudin, C., Cook, G., Jackson, G.H. & Child, J.A. (2010) First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet, 376, 1989-1999.
37. Nordentoft, I., Birkenkamp-Demtroder, K., Agerbaek, M., Theodorescu, D., Ostenfeld, M.S., Hartmann, A., Borre, M., Orntoft, T.F. & Dyrskjot, L. (2012) miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer. BMC Medical Genomics, 5, 40.
38. Novotny, G.W., Sonne, S.B., Nielsen, J.E., Jonstrup, S.P., Hansen, M.A., Skakkebaek, N.E., Rajpert-De Meyts, E., Kjems, J. & Leffers, H. (2007) Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death and Differentiation, 14, 879-882.
39. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V. & Mendell, J.T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
40. Ozata, D.M., Caramuta, S., Velazquez-Fernandez, D., Akcakaya, P., Xie, H., Hoog, A., Zedenius, J., Backdahl, M., Larsson, C. & Lui, W.O. (2011) The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocrine-Related Cancer, 18, 643-655.
41. Peltier, H.J. & Latham, G.J. (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA, 14, 844-852.
42. Pichiorri, F., Suh, S.S., Ladetto, M., Kuehl, M., Palumbo, T., Drandi, D., Taccioli, C., Zanesi, N., Alder, H., Hagan, J.P., Munker, R., Volinia, S., Boccadoro, M., Garzon, R., Palumbo, A., Aqeilan, R.I. & Croce, C.M. (2008) MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proceedings of the National Academy of Sciences of the USA, 105, 12885-12890.
43. van Rhee, F., Szymonifka, J., Anaissie, E., Nair, B., Waheed, S., Alsayed, Y., Petty, N., Shaughnessy, J.D. Jr, Hoering, A., Crowley, J. & Barlogie, B. (2010) Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy. Blood, 116, 1220-1227.
44. Sanchez-Vega, B. & Gandhi, V. (2009) Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1). British Journal of Haematology, 144, 856-864.
45. Selvanayagam, P., Blick, M., Narni, F., van Tuinen, P., Ledbetter, D.H., Alexanian, R., Saunders, G.F. & Barlogie, B. (1988) Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood, 71, 30-35.
46. Shaughnessy, J.D., Zhan, F.H., Burington, B.E., Huang, Y.S., Colla, S., Hanamura, I., Stewart, J.P., Kordsmeier, B., Randolph, C., Williams, D.R., Xiao, Y., Xu, H.W., Epstein, J., Anaissie, E., Krishna, S.G., Cottler-Fox, M., Hollmig, K., Mohiuddin, A., Pineda-Roman, M., Tricot, G., van Rhee, F., Sawyer, J., Alsayed, Y., Walker, R., Zangari, M., Crowley, J. & Barlogie, B. (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood, 109, 2276-2284.
47. Srinivasan, S., Patric, I.R. & Somasundaram, K. (2011) A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One, 6, e17438.
48. Walker, B.A., Leone, P.E., Chiecchio, L., Dickens, N.J., Jenner, M.W., Boyd, K.D., Johnson, D.C., Gonzalez, D., Dagrada, G.P., Protheroe, R.K., Konn, Z.J., Stockley, D.M., Gregory, W.M., Davies, F.E., Ross, F.M. & Morgan, G.J. (2010) A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood, 116, e56-e65.
49. Wentz-Hunter, K.K. & Potashkin, J.A. (2011) The role of miRNAs as key regulators in the neoplastic microenvironment. Molecular Biology International, 2011, 839872.
50. Woods, K., Thomson, J.M. & Hammond, S.M. (2007) Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. Journal of Biological Chemistry, 282, 2130-2134.
51. Wu, P., Walker, B.A., Brewer, D., Gregory, W.M., Ashcroft, J., Ross, F.M., Jackson, G.H., Child, A.J., Davies, F.E. & Morgan, G.J. (2011) A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment. Clinical Cancer Research, 17, 6347-6355.
52. Xiao, C., Calado, D.P., Galler, G., Thai, T.H., Patterson, H.C., Wang, J., Rajewsky, N., Bender, T.P. & Rajewsky, K. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell, 131, 146-159.
53. Xiao, C., Srinivasan, L., Calado, D.P., Patterson, H.C., Zhang, B., Wang, J., Henderson, J.M., Kutok, J.L. & Rajewsky, K. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunology, 9, 405-414.
54. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X. & Li, T. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Research, 37, D105-D110.
55. Yu, S.L., Chen, H.Y., Chang, G.C., Chen, C.Y., Chen, H.W., Singh, S., Cheng, C.L., Yu, C.J., Lee, Y.C., Chen, H.S., Su, T.J., Chiang, C.C., Li, H.N., Hong, Q.S., Su, H.Y., Chen, C.C., Chen, W.J., Liu, C.C., Chan, W.K., Li, K.C., Chen, J.J. & Yang, P.C. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48-57.
56. Zhang, J., Jima, D.D., Jacobs, C., Fischer, R., Gottwein, E., Huang, G., Lugar, P.L., Lagoo, A.S., Rizzieri, D.A., Friedman, D.R., Weinberg, J.B., Lipsky, P.E. & Dave, S.S. (2009) Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood, 113, 4586-4594.
57. Zhao, J.J., Yang, J., Lin, J., Yao, N., Zhu, Y., Zheng, J., Xu, J., Cheng, J.Q., Lin, J.Y. & Ma, X. (2009) Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nervous System, 25, 13-20.
58. Zhou, Y., Chen, L., Barlogie, B., Stephens, O., Wu, X., Williams, D.R., Cartron, M.A., van Rhee, F., Nair, B., Waheed, S., Pineda-Roman, M., Alsayed, Y., Anaissie, E. & Shaughnessy, J.D. Jr (2010) High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proceedings of the National Academy of Sciences of the USA, 107, 7904-7909.